A look at financing, M&A, and alliance activity April–June 2011 In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking – for the second quarte
Mergers & Acquisitions /In Vitro Diagnostics Clovis Oncology Inc. Roche Roche Diagnostics Roche Molecular Systems Inc. On the same day it received rights to a solid tumor compound from Pfizer Inc.